Try it
Pharmacology · Chemotherapy: bevacizumab
Sample itemA patient on bevacizumab for metastatic colorectal cancer develops new hypertension and proteinuria. Which adverse effect profile fits this drug?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Hypertension, bleeding, impaired wound healing and gastrointestinal perforation
Bevacizumab is an anti-VEGF monoclonal antibody, and VEGF blockade reduces endothelial repair and nitric oxide, causing hypertension, proteinuria, arterial thrombosis, haemorrhage, poor wound healing and bowel perforation. It is stopped before surgery.
Option by option
A. Pulmonary fibrosis
Pulmonary fibrosis is typical of bleomycin and busulfan.
B. Hypertension, bleeding, impaired wound healing and gastrointestinal perforation (correct)
Correct. These are anti-VEGF class effects.
C. Acneiform rash
Acneiform rash is typical of anti-EGFR drugs.
D. Cardiomyopathy and cumulative dose toxicity
Cumulative cardiomyopathy is typical of doxorubicin.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?